Changzhou Qianhong Biopharma CO.,LTD (SZSE: 002550)
Health Care · Pharmaceuticals · CN
CN¥6.59
+3.62% today · -27.7% 1Y
Changzhou Qianhong Biopharma CO.,LTD (SZSE: 002550) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.23B and employs 1,038 people.
Over the last twelve months the share price has lost 27.7%, trading between 5.58 and 9.49.
Tweenvest scores Changzhou Qianhong Biopharma CO.,LTD across four factors: quality 71/100, value 38/100, growth 32/100, dividend 54/100. Its strongest factor is quality.
002550 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.23B
- Revenue (TTM)
- $216.09M
- P/E
- 28.07
- EPS
- 0.23
- Dividend yield
- 2.28%
- Beta (5Y)
- 0.02
- 52-week high
- CN¥9.49
- 52-week low
- CN¥5.58
- Avg volume (3M)
- —
- Shares outstanding
- 1.25B
- Employees
- 1,038
- Next earnings
- —
About Changzhou Qianhong Biopharma CO.,LTD
Changzhou Qianhong Biopharma CO.,LTD operates as a key player in China's biopharmaceutical sector, specializing in the research, development, production, and distribution of biological drugs, with a core focus on enzyme and polysaccharide-based compounds. The company's product lineup features a variety of active pharmaceutical ingredients (APIs). These include a range of anticoagulants such as heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium, alongside pancreatin for digestive aid, asparaginase for antineoplastic applications, kallidinogenase kallikrein for treating microcirculation disorders, and heparinoid. Furthermore, Changzhou Qianhong provides ready-to-administer preparations, like pre-filled syringes of nadroparin calcium, enoxaparin sodium, and dalteparin sodium, all used as anticoagulants. It also supplies asparaginase injections for cancer treatment and heparin sodium injections to prevent blood clots. The company extends its reach through the export of its products internationally. Founded in 1971, Changzhou Qianhong Biopharma CO.,LTD maintains its headquarters in Changzhou, China.
- ISIN
- CNE100001070
- Founded
- 1971
- Listed since
- Feb 18, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Garden Biopharmaceutical Co.,Ltd.SZSE: 300401 | $1.25B | CN¥15.41 | -3.45% |
| Zhejiang Xianju Pharmaceutical Co., Ltd.SZSE: 002332 | $1.25B | CN¥8.64 | +0.35% |
| Shandong Xinhua Pharmaceutical Company LimitedSEHK: 719 | $1.24B | HK$5.80 | +0.52% |
| Jiangsu Yahong Meditech Co., Ltd.SHSE: 688176 | $1.23B | CN¥14.60 | -0.88% |
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.22B | CN¥7.85 | +4.11% |
| HARBIN GLORIA PHARMACEUTICALS Co., LTDSZSE: 002437 | $1.21B | CN¥3.65 | +4.29% |
| Aurisco Pharmaceutical Co.,Ltd.SHSE: 605116 | $1.21B | CN¥20.07 | +2.40% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.20B | CN¥39.40 | -1.38% |
Figures last refreshed Oct 4, 2026.